Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Expert consensus on the perioperative management of liver cancer treated with Yttrium-90 selective internal radiation therapy (2026 edition)].

Created on 10 Jul 2026

Authors

Committee of the Tumor Interstitial Implantation Therapy Professional, Chinese Anti-Cancer Association, Interventional Therapy Quality Control Center of Shanghai

Published in

Zhonghua nei ke za zhi. Volume 65. Issue 7. Pages 707-716. Jul 01, 2026.

Abstract

To improve the clinical efficacy and quality of perioperative care for patients with liver cancer undergoing Yttrium-90 selective internal radiation therapy (90Y-SIRT) and to standardize perioperative management and radiation safety practices, experts from relevant fields in China, led by the Tumor Interstitial Implantation Therapy Professional Committee of the Chinese Anti-Cancer Association and the Interventional Therapy Quality Control Center of Shanghai, developed this expert consensus on the perioperative management based on the clinical application and experience of 90Y-SIRT in China, together with relevant domestic literature. The final consensus covers patient selection and treatment decision-making for 90Y-SIRT, radiation protection and safety management, perioperative stratified management strategies, and discharge preparation and follow-up management. This consensus provides guidance and a practical framework for the perioperative management of patients undergoing 90Y-SIRT.

PMID:
42427043
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement